
Cutaneous melanoma is disproportionately lethal among skin cancers, and as incidence rates of cutaneous melanoma continue to rise in the United States, so does the importance of managing melanoma cases in alignment with personalized prognoses.

Aaron S. Farberg, MD of Texas Dermatology Associates, is a board-certified dermatologist and Mohs surgeon that specializes in skin cancer and cosmetic dermatology.

Published: July 27th 2021 | Updated: